Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Diagnosis of concomitant inducible laryngeal obstruction and asthma

Lee JW, Tay TR, Paddle P, Richards AL, Pointon L, Voortman M, Abramson MJ, Hoy R, Hew M

(2018), Clin Exp Allergy, 48(12), 1622-1630

DOI: 10.1111/cea.13185

A qualitative investigation into the patient-centered goal-setting practices of allied health clinicians working in rehabilitation

Cameron LJ, Somerville LM, Naismith CE, Watterson D, Maric V, Lannin NA

(2018), Clin Rehabil, 32(6), 827-840

DOI: 10.1177/0269215517752488

Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals

Woolnough EL, Hoy JF, Cheng AC, Walker RG, Chrysostomou A, Woolley I, Langham F, Moso MA, Weeraratne A, Trevillyan JM

(2018), AIDS, 32(13), 1829-1835

DOI: 10.1097/QAD.0000000000001901

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method

Tsiamis E, Millar J, Baxi S, Borg M, De Ieso P, Elsaleh H, Foroudi F, Higgs B, Holt T, Martin J, Moretti K, Pryor D, Skala M, Evans S

(2018), Radiother Oncol, 128(2), 308-14

DOI: 10.1016/j.radonc.2018.04.017

An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging

Smith RL, Hanlon M, Panettieri V, Millar JL, Matheson B, Haworth A, Franich RD

(2018), Brachytherapy, 17(1), 111-121

DOI: 10.1016/j.brachy.2017.08.004

Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management

Sampurno F, Zheng J, Di Stefano L, Millar JL, Foster C, Fuedea F, Higano C, Hulan H, Mark S, Moore C, Richardson A, Sullivan F, Wenger NS, Wittmann D, Evans S

(2018), J Urol, 200(2), 319-326

DOI: 10.1016/j.juro.2018.02.071

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study

Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Severi G, Hopper JL, Giles GG

(2018), Cancer Causes Control, 29(1), 93-102

DOI: 10.1007/s10552-017-0981-0

Brachytherapy-based radiotherapy with androgen deprivation for management of high-risk prostate cancer - time to reverse the declining trend?

Ong WL, Yaxley JW, Millar JL

(2018), BJU Int, 122 Suppl 5, 43591

DOI: 10.1111/bju.14487

Optimal Treatment for High-Risk Prostate Cancer

Ong WL, Koh TL, Millar J

(2018), JAMA, 320(4), 404-405

DOI: 10.1001/jama.2018.6709

Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy

Ong WL, Evans SM, Millar JL

(2018), J Med Imaging Radiat Oncol, 62(2), 256-261

DOI: 10.1111/1754-9485.12699

In Regard to Yang et al

Ong WL, Evans S, Millar J

(2018), Int J Radiat Oncol Biol Phys, 100(5), 1294-1295

DOI: 10.1016/j.ijrobp.2018.01.019

Development of Indicators to Assess Quality of Care for Prostate Cancer

Nag N, Millar J, Davis ID, Costello S, Duthie JB, Mark S, Delprado W, Smith D, Pryor D, Galvin D, Sullivan F, Murphy °C, Roder D, Elsaleh H, Currow D, White C, Skala M, Moretti KL, Walker T, De Ieso P, Brooks A, Heathcote P, Frydenberg M, Thavaseelan J, Evans SM

(2018), Eur Urol Focus, 4(1), 57-63

DOI: 10.1016/j.euf.2016.01.016

Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03

MacManus M, Fisher R, Roos D, O'Brien P, Macann A, Davis S, Tsang R, Christie D, McClure B, Joseph D, Jayamohan J, Seymour JF

(2018), J Clin Oncol, 36(29), 2918-2925

DOI: 10.1200/JCO.2018.77.9892

Understanding the Relationship Between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy

Liu J, Dwyer T, Marriott K, Millar J, Haworth A

(2018), IEEE Trans Vis Comput Graph, 24(1), 319-329

DOI: 10.1109/TVCG.2017.2744418

Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy

Her EJ, Reynolds HM, Mears C, Williams S, Moorehouse C, Millar JL, Ebert MA, Haworth A

(2018), Phys Med Biol, 63(13), 135011

DOI: 10.1088/1361-6560/aac814

Application of the 'Spiking' method to the measurement of low dose radiation (≤ 1Gy) using alanine dosimeters

Geso M, Ackerly T, Lim SA, Best SP, Gagliardi F, Smith CL

(2018), Appl Radiat Isot, 133, 111-116

DOI: 10.1016/j.apradiso.2018.01.003

Dose response and stability of water equivalent PRESAGE® dosimeters for synchrotron radiation therapy dosimetry

Gagliardi FM, Franich RD, Geso M

(2018), Phys Med Biol, 63(23), 235027

DOI: 10.1088/1361-6560/aaf1f5

Water equivalent PRESAGE® for synchrotron radiation therapy dosimetry

Gagliardi FM, Day L, Poole CM, Franich RD, Geso M

(2018), Med Phys, 45(3), 1255

DOI: 10.1002/mp.12745

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination

Evans SM, Murphy DG, Davis ID, Sengupta S, Borzeshi EZ, Sampurno F, Millar JL

(2018), Asia Pac J Clin Oncol, 14(5), e412-19

DOI: 10.1111/ajco.12875

Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria

Evans MA, Millar JL, Earnest A, Frydenberg M, Davis ID, Murphy DG, Kearns PA, Evans SM

(2018), Med J Aust, 208(10), 439-443

DOI: 10.5694/mja17.00559

283 284 285 286 287